Nektar Therapeutics | NKTR - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
ALKERMES USD 1.36B 570.52M 2026-03
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 31.48B 2.42B 2026-03
Baxter International USD 6.85B 25M 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Cara Therapeutics USD 31.54M 6.9M 2025-12
Cipla INR 241.47B 7.71B 2026-03
Dr.Reddys Laboratories INR 301.79B 4.24B 2026-03
Eisai JPY 761.64B 79.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 1B 177.83M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
MacroGenics USD 182.52M 37.42M 2026-03
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Xencor USD 482.85M 116.97M 2026-03